BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30271201)

  • 1. Expressions and prognostic values of the
    Liu ZL; Bi XW; Liu PP; Lei DX; Wang Y; Li ZM; Jiang WQ; Xia Y
    Cancer Manag Res; 2018; 10():3521-3532. PubMed ID: 30271201
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer.
    Li Y; Huang J; Yang D; Xiang S; Sun J; Li H; Ren G
    Oncol Lett; 2018 Jun; 15(6):9216-9230. PubMed ID: 29844824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of E2F family members in the diagnosis and prognosis of head and neck squamous cell carcinoma.
    Li Y; Huang Y; Li B; Yang K
    BMC Med Genomics; 2023 Feb; 16(1):38. PubMed ID: 36855110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of E2F Family Members in Human Gastric Cancer.
    Li S; Yang X; Li W; Chen Z
    Front Oncol; 2021; 11():625257. PubMed ID: 34532281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma.
    Sun CC; Zhou Q; Hu W; Li SJ; Zhang F; Chen ZL; Li G; Bi ZY; Bi YY; Gong FY; Bo T; Yuan ZP; Hu WD; Zhan BT; Zhang Q; Tang QZ; Li DJ
    Aging (Albany NY); 2018 May; 10(5):973-987. PubMed ID: 29754146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic role of E2F transcription factors in high-grade glioma.
    Yu H; Li Z; Wang M
    CNS Neurosci Ther; 2020 Jul; 26(7):741-753. PubMed ID: 32064771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Analysis of E2F Expression and Its Relation in Colorectal Cancer Prognosis.
    Xu Z; Qu H; Ren Y; Gong Z; Ri HJ; Zhang F; Shao S; Chen X; Chen X
    Int J Gen Med; 2022; 15():4849-4870. PubMed ID: 35585998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.
    Huang YL; Ning G; Chen LB; Lian YF; Gu YR; Wang JL; Chen DM; Wei H; Huang YH
    Cancer Manag Res; 2019; 11():1725-1740. PubMed ID: 30863181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic values of
    Manicum T; Ni F; Ye Y; Fan X; Chen BC
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30487158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression patterns and the prognostic value of the SMYD family members in human breast carcinoma using integrative bioinformatics analysis.
    Song J; Liu Y; Chen Q; Yang J; Jiang Z; Zhang H; Liu Z; Jin B
    Oncol Lett; 2019 Apr; 17(4):3851-3861. PubMed ID: 30930987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E2F family as potential biomarkers and therapeutic targets in colon cancer.
    Yao H; Lu F; Shao Y
    PeerJ; 2020; 8():e8562. PubMed ID: 32117628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.
    Wu HT; Liu J; Li GW; Shen JX; Huang YT
    Oncotarget; 2017 May; 8(22):36279-36288. PubMed ID: 28422733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma.
    Zhang C; Cui Y; Wang G; Zhao W; Zhao H; Huang X; Zhang M; Li W
    J Healthc Eng; 2021; 2021():5790416. PubMed ID: 34531966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F3/5/8 serve as potential prognostic biomarkers and new therapeutic direction for human bladder cancer.
    Gan Z; Abudurexiti A; Hu X; Chen W; Zhang N; Sang W
    Medicine (Baltimore); 2024 Jan; 103(2):e35722. PubMed ID: 38215110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Potential Therapeutic Target for E2F1 and Prognostic Factors of E2F1/2/3/5/7/8 in Human Gastric Cancer.
    Liu X; Hu C
    Mol Ther Methods Clin Dev; 2020 Sep; 18():824-838. PubMed ID: 32953933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer.
    Han Z; Mo R; Cai S; Feng Y; Tang Z; Ye J; Liu R; Cai Z; Zhu X; Deng Y; Zou Z; Wu Y; Cai Z; Liang Y; Zhong W
    Front Cell Dev Biol; 2022; 10():831329. PubMed ID: 35531101
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Zhou Q; Zhang F; He Z; Zuo MZ
    Front Oncol; 2019; 9():161. PubMed ID: 30967995
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression and prognostic analyses of early growth response proteins (EGRs) in human breast carcinoma based on database analysis.
    Fei Y; Yu H; Huang S; Chen P; Pan L
    PeerJ; 2019; 7():e8183. PubMed ID: 31844579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma.
    Liu XS; Gao Y; Liu C; Chen XQ; Zhou LM; Yang JW; Kui XY; Pei ZJ
    Front Oncol; 2020; 10():606735. PubMed ID: 33604289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of the E2F Transcription Factor Family in Human Lung Adenocarcinoma.
    Wang Q; Liu J; Cheang I; Li J; Chen T; Li Y; Yu B
    Int J Gen Med; 2022; 15():5973-5984. PubMed ID: 35811776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.